Schistosomiasis in Africa: An emerging tragedy in our new global health decade

PLoS Neglected Tropical Diseases

Volumn 3, Issue 9, 2009, Pages

  Hotez, Peter J ^a,b   Fenwick, Alan ^c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b SABIN VACCINE INSTITUTE   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; PRAZIQUANTEL; RECOMBINANT VACCINE; SCHISTOSOMIASIS HAEMATOBIA VACCINE; SCHISTOSOMIASIS MANSONI VACCINE; UNCLASSIFIED DRUG;

AFRICA; ANEMIA; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG MONITORING; EDITORIAL; ENDEMIC DISEASE; FUNDING; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH PROGRAM; HUMAN; INFECTION PREVENTION; INFECTION RISK; MORTALITY; PREVALENCE; PUBLIC HEALTH; SCHISTOSOMIASIS; TABLET; TREATMENT DURATION;

EID: 70449504005     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000485     Document Type: Editorial

References (23)

1. Hotez PJ (2008) Forgotten people, forgotten diseases: the neglected tropical diseases and their impact on global health and development. Washington (D. C.): American Society of Microbiology. 215 p.
2. Hotez P (2009) Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin Pharmacol Ther 85: 659-664.
3. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425. (Pubitemid 43949139)
4. Hotez PJ, Kamath A (2009) Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 3: e412. doi:10.1371/journal.pntd.0000412.
5. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125-139. (Pubitemid 36561364)
6. King CH, Dangerfield-Cha M (2008) The unacknowledged impact of chronic schistosomiasis. Chronic Illn 4: 65-79.
7. Kjetland EF, Ndhlovu PD, Gorno E, Mduluza T, Midzi N, et al. (2006) Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 20: 593-600. (Pubitemid 43731604)
8. Gabrielli AF, Toure S, Sellin B, Sellin E, Ky C, et al. (2006) A combined school- and community-based campaign targeting all school-age children of Burkina Faso against schistosomiasis and soil-transmitted helminthiasis: performance, financial costs and implications for sustainability. Acta Trop 99: 234-242. (Pubitemid 44755139)
9. Koukounari A, Gabrielli AF, Toure S, Bosque-Oliva E, Zhang Y, et al. (2007) Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J Infect Dis 196: 659-669. (Pubitemid 47293846)
10. Koukounari A, Fenwick A, Whawell S, Kabatereine NB, Kazibwe F, et al. (2006) Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy. Am J Trop Med Hyg 75: 278-286. (Pubitemid 46941345)
11. Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming F, et al. (2009) The schistosomiasis control initiative (SCI) rationale, development and implementation from 2002-2008. Parasitology. E-pub ahead of print 27 July 2009. doi:10.1017/S0031182009990400.
12. Frost LJ, Reich MR (2008) Access: how do good technologies get to poor people in poor countries? Cambridge (Massachusetts): Harvard University Press. 249 p. Available: http://www.accessbook.org/download/AccessBook.pdf. Accessed 4 September 2009.
13. Hotez PJ, Fenwick A, Savioli L, Molyneux DH (2009) Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373: 1570-1575.
14. Fenwick A, Rollinson D, Southgate V (2006) Implementation of human schistosomiasis control: challenges and prospects. Adv Parasitol 61: 567-622. (Pubitemid 43777028)
15. Fenwick A, Webster JP (2006) Schistosomiasis: challenges for control, treatment and drug resistance. Curr Opin Infect Dis 19: 577-582. (Pubitemid 44665464)
16. Doenhoff MJ, Hagan P, Cioli D, Southgate V, Pica-Mattoccia L, et al. (2009) Praziquantel: Its use in control of schistosomiasis in sub-saharan africa and current research needs. Parasitology. E-pub ahead of print 13 March 2009. doi:10.1017/S0031182009000493.
17. Doenhoff MJ, Cioli D, Utzinger J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21: 659-667.
18. Keiser J, Utzinger J (2007) Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr Opin Infect Dis 20: 605-612. (Pubitemid 350059520)
19. McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis. Clin Microbiol Rev 21: 225-242.
20. Hotez PJ, Bethony JM, Oliveira SC, Brindley PJ, Loukas A (2008) Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis. Expert Rev Vaccines 7: 745-752.
21. Bergquist R, Utzinger J, McManus DP (2008) Trick or treat: The role of vaccines in integrated schistosomiasis control. PLoS Negl Trop Dis 2: e244. doi:10.1371/journal.pntd.0000244. (Pubitemid 352002887)
22. Savioli L, Stansfield S, Bundy DA, Mitchell A, Bhatia R, et al. (2002) Schistosomiasis and soiltransmitted helminth infections: forging control efforts. Trans R Soc Trop Med Hyg 96: 577-579. (Pubitemid 36231472)
23. Fenwick A (2006) Waterborne infectious diseases-could they be consigned to history? Science 313: 1077-1081.